Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1393–1416 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Type 2 Diabetes Mellitus
Interventions: PF-04937319 once-daily, PF-04937319 split-dose, Sitagliptin once-daily; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 8
States / cities: DeLand, Florida • South Miami, Florida • High Point, North Carolina + 3 more

Conditions: Asthma
Interventions: Albuterol eMDPI DS, albuterol; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 13 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 29
States / cities: Birmingham, Alabama • Los Angeles, California • Stockton, California + 24 more

Conditions: Allergic Conjunctivitis
Interventions: AC-170 0.24%, AC-170 0%; Drug
Lead sponsor: Aciex Therapeutics, Inc.; Industry
Eligibility: 10 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Andover, Massachusetts

Conditions: Type 2 Diabetes Mellitus
Interventions: ORMD-0801 (qd), ORMD-0801 (bid), ORMD-0801 (tid), Placebo; Drug · Other
Lead sponsor: Oramed, Ltd.; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Tustin, California

Conditions: Acromegaly
Interventions: Pasireotide; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 3
States / cities: Los Angeles, California • Ann Arbor, Michigan • New York, New York

Conditions: Diabetes, Diabetes Mellitus, Type 1
Interventions: insulin degludec, insulin glargine, insulin aspart; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 629 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 59
States / cities: Birmingham, Alabama • Huntsville, Alabama • Peoria, Arizona + 49 more

Conditions: HIV, Cognition - Other, Impaired Driving
Interventions: Speed of Processing Training, Internet Navigational; Behavioral · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 40 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Hematologic Diseases
Interventions: Case vignette-based teaching of cell recognition, Compare-contrast basic science teaching of cell recognition; Other
Lead sponsor: The Reading Hospital and Medical Center; Other
Eligibility: 26 Years to 40 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: West Reading, Pennsylvania

Conditions: Tissue and Organ Procurement, Health Behavior
Interventions: video; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 15 Years and older
Enrollment: 973 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: General Anesthesia
Interventions: HSK3486, Propofol; Drug
Lead sponsor: Haisco-USA Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 465 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 21
States / cities: Florence, Alabama • Sheffield, Alabama • Miami, Florida + 15 more

Conditions: Healthy Male Volunteers
Interventions: NXL104, Ceftaroline, Placebo Infusion, Ceftazidime, Moxifloxacin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Breast Cancer
Interventions: Verbal and Written Instruction, Verbal and Written Plus Simulation; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 19 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Type 2 Diabetes
Interventions: glargine, detemir; Drug
Lead sponsor: Diabetes Care Center; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Salinas, California

Conditions: Dry Eye Disease
Interventions: Lifitegrast, Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years and older
Enrollment: 711 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 41
States / cities: Birmingham, Alabama • Chandler, Arizona • Artesia, California + 33 more

Conditions: Age-Related Macular Degeneration
Interventions: E10030, ranibizumab, E10030 sham intravitreal injection; Drug
Lead sponsor: Ophthotech Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 627 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 49
States / cities: Tucson, Arizona • Fresno, California • La Jolla, California + 43 more

Conditions: Hypertension
Interventions: QUARTET LDQT, Candesartan; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Bloomingdale, Illinois • Chicago, Illinois

Conditions: Sunscreen Agents
Interventions: SPF 50 Y65 110 (BAY987519), SPF 50 Y51 002 (BAY987519), SPF 15 V27 104 (BAY987519), Sodium chloride [NaCl]; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Pinellas Park, Florida

Conditions: Obesity & Overweight
Interventions: App + Fitness Tracker, App Only, Control Group; Behavioral
Lead sponsor: BetterMe Limited; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Gastroesophageal Reflux
Interventions: Dexlansoprazole, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 43
States / cities: Tucson, Arizona • Anaheim, California • Garden Grove, California + 40 more

Conditions: Idiopathic Gastroparesis
Interventions: Global Osteopathic Manual Treatment; Other
Lead sponsor: Kathleen Brannan Brown, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Santa Rosa, California

Conditions: COVID-19, COVID19, Sars-CoV2, SARS-Cov-2
Interventions: Hydroxychloroquine, Placebo; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Trauma-related Wound, Burn, Partial Thickness
Interventions: Procellera®, Standard of Care; Device · Other
Lead sponsor: The Metis Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Testosterone's Effects on Threat Perception/Response
Interventions: Testosterone; Drug
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Insomnia, Fibromyalgia
Interventions: CBT; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma

A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)

A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes

Speed of Processing Training in Adults With HIV

Comparison of Educational Methods for Teaching Peripheral Blood Smears

Community Trial to Enhance Organ Donation

Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery

A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers

Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers

A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes

A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

Test the Phototoxicity of Sunscreen Products

Evaluation of a Mobile Wellness Application and Wearable Fitness Tracker on Weight Management and Health Outcomes

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Effects of Global Osteopathic Manual Treatments in Patients With Idiopathic Gastroparesis

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

Procellera® Compared to Standard of Care Treatment in Mitigating Biofilm Formation in Acute Trauma and Burn Wounds

Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance

Web-based CBT for Insomnia Patients With Fibromyalgia